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Abstract A semi-quantitative multiplex PCR assay for the
diagnosis of bacterial vaginosis (BV) was evaluated in a pro-
spective study in a population of Dutch women with com-
plaints of abnormal vaginal discharge. The PCR targets
Gardnerella vaginalis, Atopobium vaginae, Megasphaera
phylotype 1, Lactobacillus crispatus and Lactobacillus iners.
Together with a short questionnaire, a vaginal swab for PCR
and vaginal smear for microscopy were taken by their general
practitioner or gynaecologist. Data from 151 women (median
age 32) were available. Nugent Score (NS) was used to clas-
sify the samples and 83 samples were classified as normal (NS
0–3), 13 as intermediate (NS 4–6), and 55 as bacterial vagi-
nosis (NS 7–10). In women with a NS of 7–10, PCR detected
Gardnerella vaginalis, Atopobium vaginae andMegasphaera
phylotype 1 in respectively, 96 %, 87 % and 60 %, whereas in
women with a NS of 1–3 these species were detected in 27 %,
6 % and 2 % (P <0.001). A ratio of Lactobacillus crispatus
over Lactobacillus iners of <1 (as calculated from the quanti-
fication cycle value (Cq)) was present in women with a NS of
7–10 in 66 % versus 33 % in women with a NS of 1–3 (P
<0.001). The BV-PCR displayed a sensitivity of 92 % and
specificity of 96 % with a positive predictive value of 94 %
and a negative predictive value of 95 %. The Lactobacillus-
index improved the correct classification of samples where
only one of the other bacterial species was detected. Com-
pared to the Nugent Score this multiplex qPCR offers a con-
venient tool for performing observer independent diagnosis of
BV.
Introduction
Abnormal vaginal discharge is the most common
gynaecological condition for which a general practitioner is
consulted. In the Netherlands there is an estimated incidence
of 40–50 per 1,000 female patients per annum [1]. Trichomo-
nas infections,Candida albicans infections, and bacterial vag-
inosis (BV) are among the top three causes of abnormal vag-
inal discharge. Moreover, BV has been associated with in-
creased risk of adverse sequelae, such as preterm delivery,
low birth weight, pelvic inflammatory disease and enhanced
risk of acquiring STI [2].
Classically, BV is diagnosed according to the full criteria of
Amsel et al. [3] or solely based on microscopy using either
direct (wet mount) microscopy or microscopic examination of
a Gram-stained vaginal specimen [4]. Routine culture of gen-
ital specimen reveals only part of the vaginal microbiota, and
the presence of a culturable, well-known BV-associated spe-
cies like Gardnerella vaginalis is relatively unspecific for di-
agnosis of BV [5].
Recently, cultivation-independent methods like PCR
have revealed that the presence of newly discovered vagi-
nal species such as Atopobium vaginae , unknown
Clostridiales and Megasphaera spp., might be diagnostic
of BV [6]. As the different vaginal species can be part of
the normal vaginal microbiota, quantification can greatly
improve the performance of these PCR-assays for diagno-
sis of BV [7–10]. Furthermore, the microscopic
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examination of vaginal specimen by the Nugent method is
based on the relative abundance of Lactobacillus
morphotypes (large Gram positive rods) compared to the
abundance of bacterial morphotypes suggestive of BV, but
it does not discriminate between the different Lactobacillus
spec ies . However, the ra t io in which di f fe ren t
Lactobacillus species appear in vaginal specimen can be
predictive for normal or abnormal microflora: L. crispatus
is found mainly in females with healthy vaginal microbio-
ta, whereas L. iners is detected both in healthy and dis-
turbed vaginal microbiota [9, 11–14]. The present study
describes the development of a multiplex qPCR assay for
the semi-quantitative detection of well-recognized BV-as-
sociated marker organisms and different Lactobacillus spe-
cies and its evaluation in a clinical setting.
Materials and methods
Study population
The study was approved by the local ethical board of the
investigating institute, Tergooi Hospital, Hilversum, the Neth-
erlands, and written informed consent was obtained from
participants.
A total of 159 women with self-reported complaints
of abnormal vaginal discharge presenting to their gener-
al practitioner or gynaecologist between April 2009 and
April 2010 were enrolled in the study. All enrolled were
≥18 years of age and had not received antibiotics or
vaginal medications for at least 14 days prior to enrol-
ment. The median age was 32 (range 18–62 years) and
> 95 % were Dutch Caucasians. At the time of enrol-
ment all participants completed a short questionnaire,
and both a vaginal swab for PCR (Female multi-
Collect Specimen Collection Kit; Abbott Molecular
Inc., Des Plaines, IL, USA) and vaginal smear for mi-
croscopy were taken by the physician. Only if requested
by the physician additional routine microbiological test-
ing was performed. Evaluation could not be completed
for eight of the patients, resulting in 151 patients for
evaluation.
PCR set-up
Based on the literature and preliminary studies five bacte-
rial species were selected for a multiplex real time PCR set-
up. These included three bacterial species (Atopobium
vaginae, Gardnerella vaginalis, and Megasphaera phylo-
type 1) associated with bacterial vaginosis and two
Lactobacillus species (L. crispatus and L. iners) detected
both in the normal as well as in the disturbed vaginal mi-
crobiota [5–7, 11].
DNA was isolated from the swabs by automated DNA
extraction on an Abbott M2000sp (Abbott, Illinois, USA)
using the standard Chlamydia trachomatis/Neisseria
gonorrhoeae DNA extraction protocol as advised by the
manufacturer. The presence of the above-mentioned five
bacterial species was established by an in-house semi
quantitative real-time PCR. The specificity of the primer
sets and probes (Table 1) was checked with PRIMER
BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast/)
and all sets used were found to be highly specific for
their intended targets. In addition we tested our multiplex
qPCR with a large collection of strains both for each of the
bacterial targets as well as with related bacterial species,
and only the intended targets would show up as positive
(data not shown). The qPCR reactions (see Table 1 for
details) were performed as two multiplex reactions in a
Corbett RotorGene 6000 PCR machine (Qiagen, Hilden,
Germany) using Qiagen QuantiTect Multiplex Taq
polymerase and corresponding buffers as advised by the
manufacturer. Primer concentration was 0.5 μM for all
forward and reverse primers and 0.25 μM for all probes.
Reactions were performed in a final volume of 20 μl
containing 5 μl DNA eluate. PCR conditions consisted of
a heat-activation of the Taq polymerase of 95 °C for 10 mi-
nutes followed by 40 cycles of amplification. Each ampli-
fication cycle consisted of a denaturation step at 95 °C for
15 seconds and an annealing/amplification step at 55 °C
for one minute. In all qPCR runs positive controls for all
targets as well as negative controls (H2O instead of puri-
fied sample DNA) were always included. In addition mul-
tiplex I (See Table 1) included a primer/probe set for de-
tection of human β-globulin DNA to check for adequate
sample collection and preservation and isolation of DNA
of sufficient quality. The qPCR results of clinical samples
were only considered valid if the β-globulin PCR resulted
in a quantification cycle (Cq) value ≤35 and second deriv-
atives of the amplification plots were calculated to deter-
mine the fractional qPCR cycle value. Bacterial PCRs were
scored as positive if a clear S-curve was observed in the
respective amplification plot.
Lactobacillus index
For the presence of Lactobacillus species an index was
calculated: in case of ≥5 Cq value difference between the
two Lactobacillus species and a higher load of L. iners
detected, the ‘Lactobacillus-index’ (L-index) is <1 (indi-
cating a shift to disturbed vaginal microbiota); in case a
higher load of L. crispatus was detected, the L-index is
>1 (indicating healthy vaginal microbiota); in case both
Lactobacillus species were detected in the same amounts,
or both were absent, the L-index=1 (undetermined vaginal
microbiota).
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Vaginal smears
Vaginal smears were Gram-stained and scored using Nugent
Score (NS). Based on their NS patients were subdivided in
three groups: normal vaginal microbiota (NS 0–3), intermedi-
ate vaginal microbiota (NS 4–6) and bacterial vaginosis (NS
7–10). Slides were scored independently by two experienced
technicians. In case of discordant results (n=43/151; 28 %),
slides were re-examined by the same technicians, unaware of
their previous score. For vaginal smears remaining with dis-
cordant results after this second round (n=8), the microsco-
pists sat together and came to consensus after a final round of
revisions.
Statistical analysis
The Cq values for both Lactobacillus species were determined
and when appropriate the L-index (ratio of L. crispatus over
L. iners) was calculated from these Cq values as described
above. Statistical analyses were performed with SPSS, version
20.0. Proportions were compared using Pearson's X2, Fisher’s
exact test and Mann–Whitney U test where appropriate. Scat-
ter plots were prepared using Prism V6.0 for Windows
(GraphPad Software Inc., San Diego, CA).
Results
Characteristics of women enrolled in the study
For 151 women, a vaginal swab for PCR, a vaginal smear for
microscopy, informed consent and a completed questionnaire
were received. For 149 of them, additional microbiological
testing, i.e. routine culture of the genital specimen (n=149)
and molecular diagnostics for Chlamydia trachomatis and
Neisseria gonorrhoeae (n=114), Trichomonas vaginalis or
herpes simplex virus (HSV), was performed.
Of the 151 women, 83 (55 %) had normal vaginal micro-
biota, 13 (9 %) intermediate vaginal microbiota and 55 (36 %)
had bacterial vaginosis according to NS. The clinical and lab-
oratory characteristics of this population are shown in Table 2.
Sexually transmitted infections (STIs) among these 151 pa-
tients were uncommon; one woman had C. trachomatis, one
hadN. gonorrhoeae, three had T. vaginalis and three had HSV
infection. Further pathogens detected were: Candida species,
mostly C. albicans (in 39 women), Haemophilus influenzae
(in three), and Group A β-hemolytic Streptococcus (in two).
Seventy-four women used (oral) contraceptives (OC), eight
were pregnant and 115 had visited their physician for abnor-
mal vaginal discharge in the preceding two years.
Table 1 Primer sets and
amplicon length of the two
multiplex PCRs
PCR target Primer name Oligo composition (5′–3′)a Amplicon size
Multiplex 1
β-globulinb Forward GAAGAGCCAAGGACAGGTAC 268 bp
Probe [Cy5]TCTGCCGTTACTGCCCTGT
Reverse CAACTTCATCCACGTTCACC








A. vaginae Forward TAGGTCAGGAGTTAAATCTG 155 bp
Probe [HEX]CTACCAGACTCAAGCCTGCC
Reverse TCATGGCCCAGAAGACCGCC
G. vaginalis Forward GCGGGCTAGAGTGCA 206 bp
Probe [ROX]CTTCTCAGCGTCAGTAACAGC
Reverse ACCCGTGGAATGGGCC
Megasphaera phylotype 1 Forward GATGCCAACAGTATCCGTCCG 208 bp
Probe [FAM]ACAGACTTACCGAACCGCCT
Reverse CCTCTCCGACACTCAAGTTCGA
a Primers and probes were obtained from TIB MOLBIOL GmbH, Berlin, Germany. Cyanine 5 (Cy5), Fluores-
cein (FAM), X-Rhodamin (ROX) and Hexachlorfluorescein (HEX) were used as the 5′-coupled reporter
fluorophores of the hydrolysis probes used in the multiplex PCR reaction, and the 3′-coupled Black Hole
Quencers (BHQ1 and BHQ2) as quenchers
bβ-globulin PCR was used as a sample and DNA/PCR quality control. See the BMaterials and methods^ section
for explanation
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PCR-based detection of G. vaginalis, A. vaginae,
Megasphaera, L. crispatus and L. iners
In women with BV (NS 7–10), G. vaginalis, A. vaginae, and
Megasphaera phylotype 1 were present in 96 %, 87 % and
60% of the vaginal specimens, respectively, whereas in wom-
en with normal vaginal microbiota (NS 0–3) these bacteria
were detected in, respectively, 27 %, 6 % and 2 % (P
<0.001). To establish the quantitative relationship between
bacterial load and NS, bacterial loads were plotted against
the NS in scatter plots and the median Cq value at which the
bacterium was first detected among all samples was calculated
(Fig. 1). Median Cq values for G. vaginalis, A. vaginae, and
Megasphaera phylotype 1 were 20, 25 and 25, respectively.
Higher loads ofG. vaginalis (Cq≤20), ofA. vaginae (Cq≤25),
and of Megasphaera (Cq≤25) were significantly more com-
mon in women with BV than in women with normal vaginal
microbiota (P <0.001) (Table 2). An L-index <1 (shift to dis-
turbed vaginal microbiota) was present in women with BV in
66 %, compared to 33 % in women with normal vaginal mi-
crobiota according to NS (0–3) (P <0.001).
The proportion of women with G. vaginalis, A. vaginae,
Megasphaera phylotype1 detected by PCR and the calculated
L-index, stratified according to NS, are shown in Table 2.
BV-PCR assay validation
Subsequently, themultiplex qPCR assay formolecular diag-
nosis of BV (BV-PCR) was compared with the NS as refer-
ence method for the diagnosis of BV. BV-PCR was scored
positive in case≥2 BV-associated bacteria were detected,
regardless of the L-index; BV-PCR was scored negative in
case noBV-associated bacteriumwas detected, regardless of
the L-index or one BV-associated bacterium was detected
and L-index ≥1; BV-PCR was scored indeterminate in case
one BV-associated bacterium was detected and L-index <1.
Thus 55 samples were scored BV-PCR positive, 86 BV-PCR
negative and ten BV-PCR indeterminate. A correlation be-
tween BV-PCR scores (either positive, indeterminate, or
negative) and the corresponding Nugent scores (bacterial
vaginosis, intermediate, or normal) of the samples was ob-
served with negative PCR samples almost always having a
normal NS and vice versa (not shown). Sensitivity and spec-
ificity, PPVandNPVof the BV-PCRwas calculated using all
samples (n=131) for which both NS and BV-PCR results
were conclusive (either positive or negative) for diagnosis
of BV. The BV-PCRwas highly sensitive: 92 % and specific
96 % for diagnosis of BV, with a PPVof 94 % and NPVof
95 % for predicting BV.
Table 2 Clinical and laboratory findings in 151 females with abnormal vaginal discharge







Age (median) when obtaining samplea 31.7 (25–40.4) 32.3 (22.4–41.5) 33.1 (24.8–41.3) 0.981c













Patientsb with known prior events of abnormal vaginal discharge
(data based on 146/151 pts)
50 (63 %) 11 (85 %) 32 (60 %) 0.805
Known non-BV cause of vaginal discharge
-Candida sp. 21 (25 %) 5 (39 %) 13 (24 %) 0.855
-Other 7 (8 %) 1 (8 %) 2 (4 %) 0.483
Presence of Gardnerella/Atopobium/Megasphaera
Gardnerella (total no. of positive samples) 22 (27 %) 8 (62 %) 53 (96 %) <0.001
No. of samples with Cq ≤20 6 (7 %) 3 (23 %) 30 (55 %) <0.001
Atopobium (total no. of positive samples) 5 (6 %) 4 (31 %) 48 (87 %) <0.001
No. of samples with Cq ≤25 1 (1 %) 3 (23 %) 29 (53 %) <0.001
Megasphaera (total no. of positive samples) 2 (2 %) 2 (15 %) 33 (60 %) <0.001
No. of samples with Cq ≤25 0 1 (8 %) 21 (38 %) <0.001
Lactobacillus index<1 27 (33 %) 6 (46 %) 36 (66 %) <0.001
OC oral contraceptives, IUD intra uterine device
P-values are a comparison between women with NS 0–3 and those with NS 7–10
aVariables are denoted as median (interquartile range)
b Data are only available for the indicated subset of patient samples
c Group differences were tested with the Mann–Whitney U test
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Discussion
The present study describes the development and clinical
validation of a multiplex qPCR for the molecular diagnosis
of BV. The vaginal microbiota is composed of numerous
bacterial species, and recently researchers sought for corre-
lations between the presence or absence of these species
and the clinical condition of BV [5–10, 12, 13, 15]. Build-
ing on these previous reports, we selected three BV-marker
organisms to include in our multiplex PCR. In addition,
two Lactobacillus spp. were incorporated in the qPCR as
targets. Lactobacillus spp. are believed to play an important
role in maintaining a healthy vaginal environment [16], and
where L. crispatus has been found mainly in healthy vagi-
nal microbiota, L. iners is prevalent in both healthy and
disturbed vaginal microbiota. As the vaginal microbial en-
vironment is dynamic, and transient phases between
healthy microbiota and BVoccur, we sought to incorporate
these two Lactobacillus spp. in a quantitative relation to
each other, in order to enable classification of transient
phases in vaginal specimens. Besides, the relative quanti-
tation of Gram positive rods, morphology consistent with
Lactobacillus spp., constitutes a significant component in
the frequently performed Gram-stain for diagnosing BV
and therefore it seemed reasonable to incorporate
Lactobacillus species in a molecular test for BV.
We applied the multiplex qPCR (BV-PCR) in a prospective
study among females with complaints of abnormal vaginal
discharge. In contrast to previous studies for molecular diag-
nostics of BV [5, 8, 15], participants were not recruited from
an STD clinic or among pregnant women. Indeed, having an
STI, engagement in same sex behaviour or the amenorrheic
state in pregnancy can influence vaginal microbiota [17, 18]
and therefore clinical validation of a diagnostic test in samples
from study participants recruited through general practitioners
and gynaecologists like in our study seems more appropriate.
The additional information obtained from the participants re-
vealed no significant differences between the groups with NS
0–3 and NS 7–10 with regard to either age, contraceptive use,
previous reported abnormal vaginal discharge, or other puta-
tive causes of vaginal discharge being present.
In the clinical validation of our assay, we observed that the
presence of the combination of BV-marker organisms results
in a better association with BV than the individual scores of
either of these bacteria. Adding the Lactobacillus-index,
which on its own was not predictive for BV, allowed classifi-
cation of those samples in which only one BV-marker organ-
ism was detected. Compared to the reference method (Nugent









































































































Fig. 1 Relation between Cq values and Nugent scores. Each panel
represents the Cq values obtained in the multiplex qPCR for each of the
five bacterial species tested.Circles represent Nugent score and Cq values
of a single patient grouped per patient category. Nugent scores 0–3
(indicating normal), 4–6 (intermediate) and 7–10 (indicative of bacterial
vaginosis) are presented on the X-axis, and Cq scores on the Y-axis. This
figure represents the results of all 151 patient samples analysed in this
study (see also Table 2)
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Score on vaginal specimen), our BV-PCR showed a high sen-
sitivity (92 %) and specificity (96 %) for diagnosis of BV,
confirming the potential diagnostic value of molecular diag-
nosis of BV. Also in this study we found initially 28 % of the
vaginal smears discrepant in Nugent score as classified by two
experienced technicians, whereas PCR results were highly
reproducible and technician independent (data not shown).
Furthermore, in contrast to the Nugent scoring system, in
which abundant numbers of Lactobacilli (Gram positive rods)
are scored as healthy vaginal microbiota, discrimination and
quantification of the two Lactobacillus species in the qPCR
generates information on a shift of Lactobacillus populations
in the vagina. Recently, both in studies detecting
Lactobacillus by qPCRs [5, 9, 18] or by broad range 16 s
rRNA PCRs [12, 19–21], L. iners was the most prevalent
species in the vagina, but in contrast to L. crispatus it is com-
mon and abundant in vaginal microbiotas with high concen-
trations of BV-marker organisms [11, 12]. Also in our study
we found significantly higher loads of L. iners (i.e. L-index
<1) in women with BV, although in nearly half of the women
without BVa higher load of L. iners compared to L. crispatus
(i.e. L-index <1) was detected too. Whether this condition
reflects a transient phase from predominance of healthy to
disturbed vaginal microbiota requires follow-up studies within
the individual female.
Although in previous clinical studies high loads of
G. vaginalis and A. vaginae have been shown to correlate with
a diagnosis of BV [8, 15], recently substantial variability in
G. vaginalis loads with the menstrual cycle has been demon-
strated [22]. We defined BV-PCR positivity relying on the
composition of vaginal microbiota rather than the individual
loads of the targeted BV-marker organisms. Additionally we
used the load of different Lactobacillus species in indicating a
shift in vaginal microbiota. Thus we reached an excellent sen-
sitivity and specificity for the BV-PCR assay. As with Nugent
based scoring also the BV-PCR test resulted in inconclusive
results for a small number of patients (respectively, 9 % and
7 %). From preliminary studies (data not shown), apart from
G. vaginalis and A. vaginae, Megasphaera phylotype 1 was
the most promising in molecular based diagnosis of bacterial
vaginosis. It is possible that by adding other relevant species
to a multiplex PCR themolecular diagnosis of BV can be even
more refined compared to our BV-PCR assay.
In conclusion, compared to the reference Nugent score in
females suffering from abnormal vaginal discharge, the de-
scribed multiplex qPCR was found to be a reliable tool for
diagnosis of BV. The main advantage of the BV-PCR is that it
can be performed in a reproducible and standardized fashion
that does not depend on subjective interpretation of the exam-
iner as is the case with the frequently used scorings such as
classical wet mount microscopy or Nugent score [23]. In ad-
dition this qPCR based method can easily be incorporated in a
fully automated PCR workflow as the Qiagen QIAsymphony
and the Roche FLOW, thus expanding the existing portfolio of
high through-put routine diagnostic tests of a modern clinical
microbiological laboratory. Further development of this assay
might ultimately allow to translate it into a cheap and reliable
point-of-care test. Since BV is a common, often transient but
recurrent clinical condition, this diagnostic BV-PCR can be
applied in follow-up diagnostics within the same female. As
such it is suitable to elucidate the role of the different targeted
species in the pathogenesis of bacterial vaginosis.
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